SHG · Clinical Research Centre/Lung Cancer CDR (Pilot)
CR
Pilot environment — synthetic demographics; real de-identified pathology sample (n=62; +80 synthetic; total 142).
All patients
Patient Record · MRN SMC-181588

Patient #044

Tan Wei Jie · 55y · Male · Chinese · BMI 27.3 · ECOG 1
SVMC - Sunway Velocity · Cardiothoracic Surgery · Dr. Rajesh Kumar
IB (T2a, N0)Watchful Wait
EGFR L858RTP53
Clinical storyline

Tan Wei Jie, a 55-year-old Chinese male (never, ECOG 1), presented in 2024-01 with persistent dry cough > 6 weeks. Workup confirmed Adenosquamous Carcinoma (Stage I, EGFR L858R). The MDT recommended curative-intent surgery. Current status: Watchful Wait.

HPE Results
Adenosquamous carcinoma, predominant moderately differentiated squamous cell carcinoma, no LVI, no STATS, stage IB (T2a, N0, Mx)
Clinical Stage
IB (T2a, N0)
Pathological Stage
IB (T2a, N0, Mx)
Adenocarcinoma Subtype
Adenosquamous carcinoma
CEA (ng/mL)
4.5
Tumor (CT/PET)
3.5 cm
PET SUV
10.14
NGS Results
1. EGFR Exon 21 Mutation (L858R)
2. TP53 S241F mutation